Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-World Evidence Observational Study to Evaluate the Safety of iDose® TR (Travoprost Intracameral Implant) 75 µg in an Office-Based Surgery Setting

NCT07816692 is registered in ClinicalTrials.gov with Glaukos Corporation as lead sponsor.

NCT NCT07816692
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07816692 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-World Evidence Observational Study to Evaluate the Safety of iDose® TR (Travoprost Intracameral Implant) 75 µg in an Office-Based Surgery Setting
Lead sponsor
Glaukos Corporation
Phase
Observational
Overall status
Recruiting
Start date
May 13, 2026
Completion date
March 31, 2027
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ocular hypertension (oht), open angle glaucoma (oag)